List of insiders holdings for GENELUX Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Szalay Aladar 10% Owner | 2024-05-09 16:38:35 | 0 3,989,547 | 3,989,547 | Form 4 |
| Thomas John Director | 2023-12-14 20:58:32 | 463,460 0 | 463,460 | Form 4 |
| Zindrick Thomas President and CEO | 2023-09-15 20:06:55 | 250,000 0 | 250,000 | Form 4 |
| Scigalla Paul Chief Medical Officer | 2023-01-25 19:25:36 | 163,883 0 | 163,883 | Form 3 |
| Zak Lourie S. Chief Financial Officer | 2023-09-12 16:19:27 | 150,000 0 | 150,000 | Form 4 |
| Ryder Sean General Counsel | 2023-09-21 16:30:38 | 140,572 0 | 140,572 | Form 4 |
| Zhang Qian Associate VP, Research | 2023-05-02 16:26:03 | 139,333 200 | 139,533 | Form 4 |
| Smalling Ralph Head of Regulatory | 2023-09-12 16:22:03 | 66,065 0 | 66,065 | Form 4 |
| Cappello Joseph VP, Pharmaceutical Development | 2023-09-12 16:23:09 | 65,000 0 | 65,000 | Form 4 |
| Samuelson Doug Vice President, Finance | 2023-09-12 16:25:20 | 40,000 0 | 40,000 | Form 4 |
| Jewett Caroline Head of Quality | 2023-10-04 16:10:09 | 22,000 0 | 22,000 | Form 4 |
| Woodward Gabe Director | 2023-05-02 16:30:22 | 4186 8176 | 12,362 | Form 4 |
| Mirabelli Mary Director | 2023-09-13 20:18:24 | 8857 0 | 8857 | Form 4 |
| Smither John W Director | 2023-09-14 20:18:41 | 6920 0 | 6920 | Form 4 |
| Tyree James L Director | 2023-12-14 20:59:42 | 3460 0 | 3460 | Form 4 |
| Yu Yong VP, Clinical Trial Operations | 2023-12-18 16:15:20 | 0 0 | 0 | Form 4 |